Allicin treats myocardial infarction in I/R through the promotion of the SHP2 axis to inhibit p-PERK-mediated oxidative stress
Aging · 2024
DOI: 10.18632/aging.205640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Tong Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Tsinghua Changgung Hospital, Medical Center, Tsinghua University, Beijing 102218, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Myocardial Infarction, Disulfides, Sulfinic Acids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Beijing Tsinghua Changgung Hospital, Medical Center, Tsinghua University, Beijing 102218, China.
- Department of Integrative Medicine Cardiology, China-Japan Friendship Hospital, Beijing 100029, China.
Zitieren
APA
Gao, T., Liu, M., Fu, D., Xue, Y., Liao, J., Yang, P., & Li, X. (2024). Allicin treats myocardial infarction in I/R through the promotion of the SHP2 axis to inhibit p-PERK-mediated oxidative stress. Aging. https://doi.org/10.18632/aging.205640
Vancouver
Gao T, Liu M, Fu D, Xue Y, Liao J, Yang P, et al. Allicin treats myocardial infarction in I/R through the promotion of the SHP2 axis to inhibit p-PERK-mediated oxidative stress. Aging. 2024. doi:10.18632/aging.205640
BibTeX
@article{Gao2024,
author = {Gao, Tong and Liu, Mengru and Fu, Dongliang and Xue, Yajun and Liao, Jiangquan and Yang, Peng and Li, Xianlun},
title = {Allicin treats myocardial infarction in I/R through the promotion of the SHP2 axis to inhibit p-PERK-mediated oxidative stress},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205640}
}
EUVIMED